GlaxoSmithKline Pharmaceuticals Limited Stock NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
19:05:08 17/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,799.90 INR | -1.97% |
|
-3.12% | +13.19% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 474B 4.95B 4.31B 4.08B 3.71B 6.93B 6.97B 48.64B 18.81B 241B 18.61B 18.19B 772B | P/E 2027 * |
40.7x | P/E 2028 * | 35.4x |
|---|---|---|---|---|---|
| Enterprise Value | 474B 4.95B 4.31B 4.08B 3.71B 6.93B 6.97B 48.64B 18.81B 241B 18.61B 18.19B 772B | EV / Sales 2027 * |
11.1x | EV / Sales 2028 * | 10x |
| Free-Float |
24.37% | Yield 2027 * |
1.05% | Yield 2028 * | 1.05% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -1.97% | ||
| 1 week | -3.12% | ||
| Current month | -8.20% | ||
| 1 month | +4.13% | ||
| 3 months | +27.11% | ||
| 6 months | +16.52% | ||
| Current year | +13.19% |
| 1 week | 2,755.9 |  | 2,878 |
| 1 month | 2,691.1 | | 3,120.7 |
| Current year | 2,088.1 | | 3,120.7 |
| 1 year | 2,088.1 | | 3,120.7 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.97% | -3.12% | - | - | 5.04B | |
| +1.21% | +2.09% | +50.82% | +100.68% | 1,014B | |
| +0.78% | +1.15% | +52.03% | +65.82% | 644B | |
| -0.04% | +3.41% | +19.42% | +71.29% | 464B | |
| -0.36% | +4.54% | +38.71% | +40.03% | 354B | |
| +1.52% | +3.46% | +20.13% | +26.08% | 265B | |
| +2.41% | +5.70% | +9.06% | +15.85% | 253B | |
| +0.90% | -1.12% | +37.67% | +43.71% | 203B | |
| +2.48% | -2.43% | -24.40% | -57.05% | 186B | |
| +2.23% | +3.65% | +33.71% | +98.49% | 183B | |
| Average | +1.02% | +0.96% | +26.35% | +44.99% | 396.31B | |
| Weighted average by Cap. | +1.18% | +1.41% | +34.96% | +61.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.57B 444M 387M 366M 333M 622M 625M 4.36B 1.69B 21.63B 1.67B 1.63B 69.25B | 47.24B 493M 430M 407M 369M 690M 694M 4.84B 1.87B 24.01B 1.85B 1.81B 76.86B |
| Net income | 11.65B 122M 106M 100M 91.14M 170M 171M 1.19B 462M 5.92B 457M 447M 18.96B | 13.42B 140M 122M 115M 105M 196M 197M 1.38B 532M 6.82B 526M 515M 21.83B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | ₹2,799.90 | -1.97% | 28,739 |
| 16/09/26 | ₹2,856.20 | +1.32% | 85,460 |
| 15/09/26 | ₹2,818.90 | -0.34% | 39,814 |
| 11/09/26 | ₹2,828.40 | -0.44% | 38,428 |
| 10/09/26 | ₹2,840.90 | -1.71% | 38,562 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
